Jianmin Pharmaceutical Group Co Ltd.SSE: 600976

Announcement on Convening 2024 Annual Performance Briefing

Mar 18, 2025 · Issued by Jianmin Pharmaceutical Group Co Ltd. via Shanghai Stock Exchange

Filed with SSE · Mar 18, 2025

On 6ix: 6ix.com/news/announcement-on-convening-2024-annual-performance-briefing-16

Announcement on Convening 2024 Annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Jianmin Pharmaceutical Group Co Ltd. on 6ix

Earlier from Jianmin Pharmaceutical

Implementation Announcement on Providing Guarantee for Bank Credit Lines of SubsidiaryJan 23, 2025
Announcement on External DonationsJan 14, 2025
Announcement on Resolution of the 30th Meeting of the 10th Board of DirectorsDec 18, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024Dec 13, 2024
Announcement on Inclusion and Renewal of the Company's Products on the Catalogue of Drugs for Basic National Medical Insurance (2024)Nov 29, 2024

Later from Jianmin Pharmaceutical

Announcement on Resolutions of the 16th Meeting of the 10th Board of SupervisorsMar 22, 2025
Announcement on Resolution of the 2024 Annual General MeetingApr 16, 2025
Announcement on Resolution of the 34th Meeting of the 10th Board of DirectorsApr 19, 2025
Announcement on the Approval of Pediatric Bezoar Antipyretic Plaster for MarketingApr 22, 2025
Announcement on Implementation of Dividend Distribution for 2024Apr 24, 2025

All Jianmin Pharmaceutical news releases

Follow Jianmin Pharmaceutical into a list and get an email when it puts out news.

Follow Jianmin Pharmaceutical